141 related articles for article (PubMed ID: 2543475)
1. Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer.
Fosså SD; Aass N
Br J Urol; 1989 May; 63(5):531-4. PubMed ID: 2543475
[TBL] [Abstract][Full Text] [Related]
2. Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients.
Wanderås EH; Fosså SD; Tretli S
Eur J Cancer; 1997 Feb; 33(2):253-62. PubMed ID: 9135497
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer.
Boulos S; Mazhar D; Warren AY; Wong HH
Future Oncol; 2017 May; 13(11):947-950. PubMed ID: 28481147
[No Abstract] [Full Text] [Related]
4. Curing metastatic cancer: lessons from testicular germ-cell tumours.
Masters JR; Köberle B
Nat Rev Cancer; 2003 Jul; 3(7):517-25. PubMed ID: 12835671
[TBL] [Abstract][Full Text] [Related]
5. The Southwest Oncology Group Study for advanced testicular cancer.
Crawford ED
Semin Urol; 1984 Nov; 2(4):244-53. PubMed ID: 6095397
[No Abstract] [Full Text] [Related]
6. Treatment of testicular intraepithelial neoplasia (intratubular germ cell neoplasia unspecified) with local radiotherapy or with platinum-based chemotherapy: a survey of the German Testicular Cancer Study Group.
Dieckmann KP; Wilken S; Loy V; Matthies C; Kleinschmidt K; Bedke J; Martinschek A; Souchon R; Pichlmeier U; Kliesch S
Ann Oncol; 2013 May; 24(5):1332-7. PubMed ID: 23293116
[TBL] [Abstract][Full Text] [Related]
7. Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
Powles T; Shamash J; Berney D; Oliver RT
Br J Cancer; 2003 Sep; 89(6):1140-1; author reply 1141-2. PubMed ID: 12966438
[No Abstract] [Full Text] [Related]
8. Stereotactic radiation therapy for residual chemorefractory primary mediastinal non-seminomatous germ cell tumor after surgical thoracotomy.
Laflamme P; Doucet C; Sirois C; Kopek N; Vanhuyse M
Pract Radiat Oncol; 2017; 7(4):260-263. PubMed ID: 28222996
[No Abstract] [Full Text] [Related]
9. [Testicular cancer--is there an indication for adjuvant or neoadjuvant systemic therapy?].
Langenkamp S; Albers P
Urologe A; 2007 Oct; 46(10):1389-90, 1392-4. PubMed ID: 17874229
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of relapsed metastatic testicular cancer.
Kollmannsberger C; Honecker F; Bokemeyer C
Expert Opin Pharmacother; 2008 Sep; 9(13):2259-72. PubMed ID: 18710351
[TBL] [Abstract][Full Text] [Related]
11. Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.
Hellesnes R; Kvammen Ø; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
Int J Cancer; 2020 Jul; 147(1):21-32. PubMed ID: 31597192
[TBL] [Abstract][Full Text] [Related]
12. [Surgery of residual masses after chemotherapy in patients with testicular cancer].
Fléchon A; Rivoire M; Berger N
Rev Prat; 2007 Feb; 57(4):389-98. PubMed ID: 17455741
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
14. Experience with PVB in non seminomatous germ-cell cancer of the testis.
Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
[No Abstract] [Full Text] [Related]
15. Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy.
Miller RE; Markt SC; O'Donnell E; Bernard B; Albiges LK; Beard C; Sweeney CJ
Eur Urol Focus; 2017 Dec; 3(6):621-628. PubMed ID: 28753801
[TBL] [Abstract][Full Text] [Related]
16. Advanced testicular cancer: treatment choices in the "land of plenty".
Garnick MB
J Clin Oncol; 1985 Mar; 3(3):294-7. PubMed ID: 2579211
[No Abstract] [Full Text] [Related]
17. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
Pizzocaro G
Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
[No Abstract] [Full Text] [Related]
18. Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer.
Heidegger I; Porres D; Veek N; Heidenreich A; Pfister D
Urol Int; 2017; 99(1):104-109. PubMed ID: 28514776
[TBL] [Abstract][Full Text] [Related]
19. [Cisplatin in the treatment of testicular carcinoma].
van Groeningen CJ; Pinedo HM
Ned Tijdschr Geneeskd; 1986 Nov; 130(44):1980-4. PubMed ID: 3022163
[No Abstract] [Full Text] [Related]
20. Controversies in the management of early-stage germ cell tumors.
Tan A; Gilligan T
Curr Oncol Rep; 2009 May; 11(3):235-43. PubMed ID: 19336016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
